Paxlovid in the Treatment of COVID-19 Patients With Uremia

NCT05386433 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
Uremia

Interventions

DRUG: Paxlovid
DRUG: standard-of-care

Sponsor

Ruijin Hospital